CFR:SIXCompagnie Financiere Richemont SA Analysis
Data as of 2026-03-09 - not real-time
$134.46
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Cullen/Frost Bankers (CFR) is trading at $134.46, which sits below its 20‑day (~$142) and 50‑day (~$139) moving averages, indicating short‑term pressure. The stock’s 30‑day volatility of ~21% and a beta near 1 suggest it moves in line with the broader market but with heightened swing potential. Technical momentum is mixed: the RSI of 35 points to oversold conditions, while the MACD histogram remains negative, signaling bearish short‑term momentum. Support at $132.14 provides a cushion, but the next resistance near $149 aligns with the 52‑week high. On the valuation side, the forward PE of 12.7 is well under the industry average of 17.4, and the price‑to‑book of 1.92 reflects a modest premium to book value. However, the discounted cash‑flow model pins a fair value around $124, implying the market is pricing in a modest premium.
Fundamentally, CFR delivered 9.5% revenue growth, a 34.5% operating margin and a 15.3% ROE, underscoring strong profitability for a regional bank. The dividend yield of 2.96% with a payout ratio under 40% and solid cash generation supports the sustainability of the payout. Analyst consensus remains “hold” with a median price target of $150, translating to roughly 12% upside from current levels. Recent earnings reports highlighted higher net interest income, reinforcing the bank’s core earnings engine. The combination of attractive dividend income, solid margins and a valuation gap to peers makes the stock a compelling income‑oriented play. Nonetheless, regulatory scrutiny typical for U.S. banks and the elevated volatility advise caution on timing any entry.
Fundamentally, CFR delivered 9.5% revenue growth, a 34.5% operating margin and a 15.3% ROE, underscoring strong profitability for a regional bank. The dividend yield of 2.96% with a payout ratio under 40% and solid cash generation supports the sustainability of the payout. Analyst consensus remains “hold” with a median price target of $150, translating to roughly 12% upside from current levels. Recent earnings reports highlighted higher net interest income, reinforcing the bank’s core earnings engine. The combination of attractive dividend income, solid margins and a valuation gap to peers makes the stock a compelling income‑oriented play. Nonetheless, regulatory scrutiny typical for U.S. banks and the elevated volatility advise caution on timing any entry.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term support at $132.14
- Oversold RSI suggesting potential bounce
- Bearish MACD indicating continued downside risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Revenue growth and strong operating margins
- Attractive dividend yield and sustainable payout
- Upside potential toward median target of $150
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Consistent profitability and solid ROE
- Stable dividend income for income investors
- Fair valuation relative to peers and industry
Key Metrics & Analysis
Financial Health
Revenue Growth9.50%
Profit Margin29.60%
P/E Ratio13.6
ROE15.31%
ROA1.23%
P/B Ratio1.9
Op. Cash Flow$274.0M
Industry P/E17.4
Technical Analysis
TrendBullish
RSI35.6
Support$132.14
Resistance$148.97
MA 20$142.20
MA 50$138.61
MA 200$130.32
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair Value$123.57
Target Price$146.07
Upside/Downside8.63%
GradeFair
TypeBlend
Dividend Yield2.96%
Risk Assessment
Beta0.99
Volatility21.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.